Atazanavir
Price | USD1.00 |
Packge | 1KG |
- Min. Order:1KG
- Supply Ability:Customized
- Time:2019-07-06
Product Details
- Product NameAtazanavir
- CAS No.198904-31-3
- EINECS No.1308068-626-2
- MFC38H52N6O7
- MW704.86
- Appearancepowderwhite to beige
- Melting point 207-2090C
- storage temp. -20°C
- density 1.178±0.06 g/cm3(Predicted)
Product NO:SP1095
Atazanavir Basic information |
Product Name: | Atazanavir |
Synonyms: | ATAZANAVIR, BISULFATE SALT;Atazanavir;(3S,8S, 9S, 12S)-2,5,6,13-Pentaazatetradecanedioic Acid;3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-dimethyl Ester;Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;(2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide;229975-97-7 (Sulfate 1:1);Aids057755 |
CAS: | 198904-31-3 |
MF: | C38H52N6O7 |
MW: | 704.87 |
EINECS: | 1308068-626-2 |
Product Categories: | API;All Inhibitors;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Chiral Reagents;Inhibitor;peptides |
Mol File: | 198904-31-3.mol |
Atazanavir Chemical Properties |
Melting point | 207-2090C |
alpha | D -47° (c = 1 in ethanol) |
storage temp. | -20°C Freezer |
Safety Information |
Hazardous Substances Data | 198904-31-3(Hazardous Substances Data) |
Atazanavir Usage And Synthesis |
Chemical Properties | Crystalline Solid |
Uses | Atazanavir is a novel azapeptide protease inhibitor (PI) |
Uses | enzyme inhibitor |
Uses | Atazanavir is a novel azapeptide HIV protease inhibitor (PI). Antiviral. |
Definition | ChEBI: A heavily substituted carbohydrazide that is an antiretroviral drug of the protease inhibitor (PI) class used to treat infection of human immunodeficiency virus (HIV). |
Uses | Atazanavir is an inhibitor of HIV-1 protease (EC50 = 2.6 nM). In isolated cells, it has additive to moderately synergistic antiviral effects when combined with other antiretroviral drugs. As a result, it is commonly used in vivo in combination therapy for HIV-1 infection. Atazanavir competitively inhibits UDP-gluronosyltransferase, which conjugates bilirubin for clearance, leading to hyperbilirubinemia in a significant portion of those receiving atazanavir therapy. |
Company Profile Introduction
Henan CoreyChem Co., Ltd, based on the original Zhengzhou Cote Chemical Research Institute, be brave in absorbing highly educated talents & overseas returnees; actively responded to Zhengzhou City High-tech Zone Government’s Special Care Policy, reorganized and founded in National University of Science and Technology Park, which is a high-tech, stock enterprise of high-end chemical Custom synthesis;The park was created by the People's Government of Henan Province, and proved by Ministry of Education and the National Science & Technology, taking the construction mode of "many college a park, and common development", mainly depends on Zhengzhou University and Henan University’s scientific research and talent advantage to set up Universities, scientific research institute and enterprise scientific research achievements transformation platform, to make high-tech enterprises incubate, is the new high-tech talent gathering base, high and new technology industry enterprise radiation base, colleges and universities technological innovation base.
Henan Coreychem Co., Ltd, facing global High-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and Rare chemicals trade. Corey have well-equipped machine, strong technical force and considerate marketing team service. We also have rich experience advantage in basic research, small scale process development, scale-up, industrial technology development & production and cost control.
Recommended supplier
-
VIP1年
- Medec Dragon Private Limited
- 198904-31-3 99%
- Inquiry
- 2024-03-19
-
VIP1年
- Atul Bioscience Ltd
- 198904-31-3 Atazanavir 99%
- Inquiry
- 2024-02-05
-
VIP1年
- Ralington Pharma
- Atazanavir 198904-31-3 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Raising Sun Pharma
- Atazanavir 98%
- Inquiry
- 2024-02-03
-
VIP1年
- Laurus Labs Ltd
- 198904-31-3 98%
- Inquiry
- 2024-02-02
-
VIP1年
- HRV Global Life Sciences
- 198904-31-3 Atazanavir 99%
- Inquiry
- 2024-01-12
-
VIP1年
- Macleods Pharmaceuticals Limited
- Atazanavir 198904-31-3 98%
- Inquiry
- 2024-01-08
-
VIP1年
- Aurobindo Pharma Limited
- Atazanavir 98%
- Inquiry
- 2024-01-06
-
VIP1年
- Dodhia Group
- Atazanavir 99%
- Inquiry
- 2024-01-03
-
VIP1年
- Mana Pharma
- Atazanavir 98%
- Inquiry
- 2023-12-30
- Since:2014-12-17
- Address: No.967,15th Floor,Unit 7, Building 1, No.70 of DianChang Road, High-tech Development Zone, Zhengzho
INQUIRY